A Safer War for Civilians?

Your correspondent suggests that science may be making the combat theater safer for soldiers.

Written byMin-Han Tan
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Your correspondent suggests that science may be making the combat theater safer for soldiers.1 She neglects to mention that one may also "measure the effects of hell on earth" in the affected civilian population. A recent extraordinary epidemiologic study, undertaken at significant risk to the interviewers, suggested an approximate Iraqi death toll of 100,000 in the recent conflict, a figure far higher than that of press accounts.2 Studies of violence and mortality have been performed in Darfur, Sudan, demonstrating high mortality rates among civilians due to armed conflict.3 These scientific studies tell us as much about ourselves as does biomonitoring. Let "collateral damage" not be an afterthought.

Min-Han Tan, MDGrand Rapids, Mich. minhan.tan@gmail.com

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies